Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
André C. Ferreira, Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 245

Showing 1-25 of 245 citing articles:

SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 685
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 494
Death by TNF: a road to inflammation
Geert Loo, Mathieu J.M. Bertrand
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 289-303
Open Access | Times Cited: 450
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 422
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Sheng‐Kai Hsu, Chia‐Yang Li, I‐Ling Lin, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8813-8835
Open Access | Times Cited: 298
Inflammasome activation at the crux of severe COVID-19
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 288
Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235
Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
Lok-Yin Roy Wong, Stanley Perlman
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 47-56
Open Access | Times Cited: 162
The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 150
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 126
SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage
Juan Ma, Fangrui Zhu, Min Zhao, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 100
COVID-19 and the role of cytokines in this disease
Amin Hasanvand
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 789-798
Open Access | Times Cited: 92
Pyroptosis-induced inflammation and tissue damage
Swathy O. Vasudevan, Bharat Behl, Vijay Rathinam
Seminars in Immunology (2023) Vol. 69, pp. 101781-101781
Open Access | Times Cited: 83
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, et al.
EBioMedicine (2022) Vol. 85, pp. 104299-104299
Open Access | Times Cited: 78
Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients
Silvia Lucena Lage, Eduardo P. Amaral, Kerry L. Hilligan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 77
Inflammasome activation in neutrophils of patients with severe COVID-19
Karen Aymonnier, Julie Ng, Laura E. Fredenburgh, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2001-2013
Open Access | Times Cited: 75
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
Daniel K. Beyer, Adriana Forero
Journal of Molecular Biology (2021) Vol. 434, Iss. 6, pp. 167265-167265
Open Access | Times Cited: 86
COVID-19: Inflammatory Profile
Yuhang Wang, Stanley Perlman
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 65-80
Open Access | Times Cited: 71
The evolution of regulated cell death pathways in animals and their evasion by pathogens
Bart Tummers, Douglas R. Green
Physiological Reviews (2021) Vol. 102, Iss. 1, pp. 411-454
Open Access | Times Cited: 69
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
W. Land
Genes and Immunity (2021) Vol. 22, Iss. 3, pp. 141-160
Open Access | Times Cited: 59
Viral manipulation of host cell necroptosis and pyroptosis
Simon Verdonck, Josephine Nemegeer, Peter Vandenabeele, et al.
Trends in Microbiology (2021) Vol. 30, Iss. 6, pp. 593-605
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top